Association pityriasis rubra pilaire et myasthénie

Agharbi, Fatima Zahra; Elbekkal, Amal; Baybay, Hanane; Meziane, Mariame; Mikou, O.; Mernissi, Fatima Zahra

doi:10.4314/pamj.v10i0.72213

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Radiographic evidence of acro-osteolysis is frequently described although only two cases of erosive arthritis have been reported [53,59]. Other rheumatological associations with PRP include myositis (specifically dermatomyositis and Wong-type dermatomyositis, with skin lesions characterized by the grouped keratotic follicular papules of PRP) [63,64], autoimmune thyroiditis [60], celiac sprue [65], systemic sclerosis [66] and myasthenia gravis [67].…”

Section: Pityriasis Rubra Pilarismentioning

confidence: 99%

Beyond plaque psoriasis – pathogenesis and treatment of other psoriasis phenotypes

Iznardo

Puig

2022

Current Opinion in Rheumatology

View full text Add to dashboard Cite

Purpose of reviewPsoriasis vulgaris is the commonest presentation of psoriatic disease, but morphologic variants such as pustular psoriasis (PP) and a closely related disease, pityriasis rubra pilaris (PRP), have been known for a long time, have been associated with rheumatologic manifestations indistinguishable from psoriatic arthritis (PsA) that may go unrecognized, and often represent a therapeutic conundrum. There is recent evidence that underlying genetic and pathogenetic differences may provide the basis for newer therapeutic approaches.Recent findingsThis narrative review highlights the clinical, genetic and pathogenetic characteristics of PP and PRP, their association with PsA and recent developments in their treatment, especially with biologic agents targeting IL-36 and other cytokines of pathogenic relevance.SummaryThe clinical manifestations of PP and PRP are less well known to rheumatologists than those of psoriasis, and recent advances in our insight on their pathogenesis may eventually overcome the therapeutic difficulties faced by dermatologists and rheumatologists in the management of these diseases and their rheumatologic manifestations.

show abstract